Ten years of institutional evidence.
Mount Sinai's skull base program has published its own report card: a ten-year comparison of endoscopic versus transcranial approaches for skull base malignancies and an eight-year technological analysis of advanced endoscopic resection. The group also led a systematic review of exclusively endoscopic resection for esthesioneuroblastoma and contributed to the International Consensus Statement on sinonasal tumors — the field's reference document.
Outcomes research here extends past survival curves: a 2025 national analysis identified risk factors for suicidal ideation in patients with skull base tumors — turning survivorship and mental health into measurable, treatable parts of care.
Selected papers.
- Surgical outcomes in patients with endoscopic versus transcranial approach for skull base malignancies: a 10-year institutional experience. British Journal of Neurosurgery, 2020. PubMed
- The Role of Advanced Endoscopic Resection of Diverse Skull Base Malignancies: Technological Analysis during an 8-Year Single Institutional Experience. Journal of Neurological Surgery Part B, 2020. PubMed
- Exclusively endoscopic surgical resection of esthesioneuroblastoma: A systematic review. World Journal of Otorhinolaryngology — Head and Neck Surgery, 2022. PubMed
- International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors. International Forum of Allergy & Rhinology, 2024. PubMed · DOI
- Risk Factors for Suicidal Ideation and Attempt in Patients With Skull Base Tumors. Otolaryngology–Head and Neck Surgery, 2025. PubMed · DOI
- Predictors of Prolonged Length of Stay After Pituitary Adenoma Resection: A Large Cohort Analysis Using the National Inpatient Sample. American Journal of Rhinology & Allergy, 2023. PubMed
Why this matters for your case.
This evidence base directly shapes how pituitary and skull base surgery is offered: which tumors are approached endoscopically, what patients are told to expect, and how follow-up is structured.